Acta Neuropathologica

, Volume 134, Issue 2, pp 317–319 | Cite as

Synchronous gemistocytic astrocytoma IDH-mutant and oligodendroglioma IDH-mutant and 1p/19q-codeleted in a patient with CCDC26 polymorphism

  • Rachael A. Vaubel
  • Thomas M. Kollmeyer
  • Alissa A. Caron
  • Emily G. Barr Fritcher
  • Jesse S. Voss
  • Haohai Liang
  • Robert B. Jenkins
  • Caterina Giannini
  • Benjamin R. Kipp
Correspondence

Supplementary material

401_2017_1727_MOESM1_ESM.pdf (306 kb)
Supplementary material 1 (PDF 306 kb)
401_2017_1727_MOESM2_ESM.pdf (53 kb)
Supplementary material 2 (PDF 53 kb)

References

  1. 1.
    Abou-El-Ardat K, Seifert M, Becker K, Eisenreich S, Lehmann M, Hackmann K et al (2017) Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomas. Neuro Oncol. doi:10.1093/neuonc/now231 PubMedPubMedCentralGoogle Scholar
  2. 2.
    Cancer Genome Atlas Research N, Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR et al (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 372:2481–2498. doi:10.1056/NEJMoa1402121 CrossRefGoogle Scholar
  3. 3.
    di Russo P, Perrini P, Pasqualetti F, Meola A, Vannozzi R (2013) Management and outcome of high-grade multicentric gliomas: a contemporary single-institution series and review of the literature. Acta Neurochir (Wien) 155:2245–2251. doi:10.1007/s00701-013-1892-9 CrossRefGoogle Scholar
  4. 4.
    Garcia Pulido P, Neal J, Halpin S, Hamandi K (2013) Multicentric oligodendroglioma: case report and review of the literature. Seizure 22:480–482. doi:10.1016/j.seizure.2013.02.018 CrossRefPubMedGoogle Scholar
  5. 5.
    Huse JT, Diamond EL, Wang L, Rosenblum MK (2015) Mixed glioma with molecular features of composite oligodendroglioma and astrocytoma: a true “oligoastrocytoma”? Acta Neuropathol 129:151–153. doi:10.1007/s00401-014-1359-y CrossRefPubMedGoogle Scholar
  6. 6.
    Jenkins RB, Xiao Y, Sicotte H, Decker PA, Kollmeyer TM, Hansen HM et al (2012) A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation. Nat Genet 44:1122–1125. doi:10.1038/ng.2388 CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Sahm F, Korshunov A, Schrimpf D, Stichel D, Jones DT, Capper D et al (2017) Gain of 12p encompassing CCND2 is associated with gemistocytic histology in IDH mutant astrocytomas. Acta Neuropathol 133:325–327. doi:10.1007/s00401-016-1657-7 CrossRefPubMedGoogle Scholar
  8. 8.
    Terakawa Y, Yordanova YN, Tate MC, Duffau H (2013) Surgical management of multicentric diffuse low-grade gliomas: functional and oncological outcomes: clinical article. J Neurosurg 118:1169–1175. doi:10.3171/2013.2.JNS121747 CrossRefPubMedGoogle Scholar
  9. 9.
    Vergani F, Sanson M, Duffau H (2009) Combined multiple surgical intervention and chemotherapy for multicentric WHO grade II glioma: a long-term follow-up study. Acta Neurochir (Wien) 151:1699–1704. doi:10.1007/s00701-009-0306-5 CrossRefGoogle Scholar
  10. 10.
    Weber RG, Sabel M, Reifenberger J, Sommer C, Oberstrass J, Reifenberger G et al (1996) Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization. Oncogene 13:983–994PubMedGoogle Scholar
  11. 11.
    Wilcox P, Li CCY, Lee M, Shivalingam B, Brennan J, Suter CM et al (2015) Oligoastrocytomas: throwing the baby out with the bathwater? Acta Neuropathol 129:147–149. doi:10.1007/s00401-014-1353-4 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  • Rachael A. Vaubel
    • 1
  • Thomas M. Kollmeyer
    • 2
  • Alissa A. Caron
    • 2
  • Emily G. Barr Fritcher
    • 3
  • Jesse S. Voss
    • 3
  • Haohai Liang
    • 4
  • Robert B. Jenkins
    • 2
  • Caterina Giannini
    • 1
  • Benjamin R. Kipp
    • 1
  1. 1.Department of Anatomic PathologyMayo ClinicRochesterUSA
  2. 2.Department of Experimental PathologyMayo ClinicRochesterUSA
  3. 3.Department of Molecular Anatomic PathologyMayo ClinicRochesterUSA
  4. 4.Anatomic PathologyWellStar Kennestone HospitalMariettaUSA

Personalised recommendations